ONCOINVENT ASA

Oncoinvent secures new patent expanding protection for Radspherin[®]

First patent from a new patent family granted in China, strengthening the long-term intellectual property protection for the Company's lead product candidate. Oslo, Norway, 19 March 2026: Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradi...